COPD, Fatigue, Mediation, Symptoms and Signs
Conditions
Brief summary
Patients with COPD will be entered. Participants will be randomized to one of three study arms: Arm 1: meditation; Arm 2: relaxation; Arm 3: Control. Hypothesis: Progressive muscle relaxation and mindfulness meditation will decrease severity of dyspnea, fatigue and care dependency.
Detailed description
Previous reports have revealed that progressive muscle relaxation and meditation are decreasing symptoms burden in chronic disease. On the other hand, no study has been conducted to determine the effects of progressive relaxation exercise and mindfulness meditation on dyspnea, fatigue and care dependency in patients with COPD. The present study investigates the effects of progressive muscle relaxation and mindfulness meditation in a single-site, 3-arm, assessor-blinded randomized, controlled study of 65 COPD patients. Arm 1: meditation; Arm 2: relaxation; Arm 3: Control.The investigators hypothesize that Progressive muscle relaxation and mindfulness meditation will decrease the severity of dyspnea, fatigue and care dependency.
Interventions
BEHAVIORALmindfullness and relaxation
three arms: mindfullness and relaxation
Sponsors
Hacettepe University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Subject)
Masking description
Single (Outcomes Assessor)
Intervention model description
Parallel Assignment
Eligibility
Sex/Gender
ALL
Age
40 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* older than 40 years * diagnosed with stage III-IV COPD * had at least primary school degree * had no cognitive dysfunction, or communication problems * were residing in Ankara.
Exclusion criteria
* history of cognitive dysfunction, or communication problems * illiteracy * applying any complementary and integrative approach during the study * participating in a pulmonary rehabilitation program during the study.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change in dyspnea | Baseline measurements, at the end of 12th week and four weeks after the completion of the interventions | Dyspnea will be measured by The Dyspnea-12 Scale. The range of total score was from 0 to 36, with higher scores demonstrating higher dyspnea level. |
| Change in fatigue | Baseline measurements, at the end of 12th week and four weeks after the completion of the interventions | Quality of live will be measured by Asthma Fatigue Scale (CAFS). The CAFS scores is standardized to 0-100 in line with the following formula, (100 × (total score-minimum value to be obtained)/range), with higher scores indicating greater fatigue. |
| Change in care dependency | Baseline measurements, at the end of 12th week and four weeks after the completion of the interventions | Quality of live will be measured by Care Dependency Scale (CDS). The sum of the scores changes from 17 to 85, with higher scores demonstrating lower dependence. |
Other
| Measure | Time frame | Description |
|---|---|---|
| Dyspnea | Baseline | The Dyspnea-12 Scale |
Countries
Turkey (Türkiye)
Outcome results
None listed